Sean P. McBurney, Ph.D.
Affiliations: | 2010 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Virology Biology, Microbiology Biology, ImmunologyGoogle:
"Sean McBurney"Parents
Sign in to add mentor| Ted M. Ross | grad student | 2010 | University of Pittsburgh | |
| (Development of broadly reactive HIV-1/AIDS virus-like particle vaccines.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hessell AJ, Shapiro MB, Powell R, et al. (2018) Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges. Journal of Virology |
| Trovato M, Maurano F, D'Apice L, et al. (2016) E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. Bmc Microbiology. 16: 152 |
| McBurney SP, Sunshine JE, Gabriel S, et al. (2016) Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates. Vaccine |
| Hessell AJ, Malherbe DC, Pissani F, et al. (2016) Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens. Journal of Immunology (Baltimore, Md. : 1950) |
| Krebs SJ, McBurney SP, Kovarik DN, et al. (2014) Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA. Plos One. 9: e113463 |
| Douradinha B, McBurney SP, Soares de Melo KM, et al. (2014) C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells. Virus Research. 179: 231-4 |
| McBurney SP, Landucci G, Forthal DN, et al. (2012) Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine. Aids Research and Human Retroviruses. 28: 1063-72 |
| Ross TM, Bhardwaj N, Eugene HS, et al. (2011) Virus-Like Particle Vaccines: Advantages and Challenges Development of Vaccines: From Discovery to Clinical Testing. 97-124 |
| McBurney SP, Ross TM. (2009) Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine. 27: 4337-49 |
| McBurney SP, Ross TM. (2008) Viral sequence diversity: challenges for AIDS vaccine designs. Expert Review of Vaccines. 7: 1405-17 |